Complex | |
AACDB_ID: | 5311 |
PDBID: | 7WD2 |
Chains: | D_B |
Organism: | Severe acute respiratory syndrome coronavirus 2, Vicugna pacos |
Method: | XRD |
Resolution (Å): | 2.69 |
Reference: | 10.1016/j.xcrm.2023.100918 |
Antibody | |
Antibody: | S43 VHH |
Antibody mutation: | No |
INN (Clinical Trial): | |
Antigen | |
Antigen: | SARS-CoV-2 spike glycoprotein RBD |
Antigen mutation: | No |
Durg Target: | P0DTC2 |
Antibody
Chain: D
Mutation: NULL
>7WD2_D|Chain C, D|Anti-RON nanobody|Vicugna pacos (30538) QVQLQESGGGLVQPGGSLRLTCAPSGFTLDYYAIGWFRQAPGKEREGVSCISSNNSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAEPDYSGVYYYTCGWTDFGSWGQGTQVTVSSHH |
Antigen
Chain: B
Mutation: NULL
>7WD2_B|Chain A, B|Spike protein S1|Severe acute respiratory syndrome coronavirus 2 (2697049) TNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKS |
Interaction
1、Solvent accessible surface areas (SASA) were calculated (Naccess V2.1.1) for each residue in antibody and antigen, respectively. The residues with SASA loss in binding of more than 1Å2 were classified as interacting residues.
Interacting residues (ΔSASA based)
D: GLU44 GLU98 PRO99 ASP100 TYR101 SER102 GLY103 VAL104 TYR105 TYR106 TYR107 THR108 GLY110 TRP111 THR112 ASP113 PHE114 GLY115 B: TYR369 PHE374 SER375 THR376 PHE377 LYS378 CYS379 TYR380 GLY381 VAL382 SER383 PRO384 THR385 GLY404 ASP405 VAL407 ARG408 PRO412 GLY413 GLN414 ASP427 VAL503 GLY504 TYR508 |
2、We defined interacting paratope-epitope residues by a distance cutoff of < 5Å . Two amino acids are considered as interacting residues if they have at least one atom within a distance of 5 Å from any atom.
Interacting residues (Atom distance based)